- Joined
- Dec 3, 2017
- Messages
- 26,290
- Reaction score
- 16,771
- Gender
- Male
- Political Leaning
- Progressive
Thiel-backed psychedelic drugmaker valued at $3.2B in Nasdaq debut
Shares of Atai Life Sciences, backed by billionaire investor Peter Thiel, surged 40 percent in their U.S. stock market debut on Friday, giving the German psychedelics startup a market cap…
nypost.com
Shares of Atai Life Sciences, backed by billionaire investor Peter Thiel, surged 40 percent in their U.S. stock market debut on Friday, giving the German psychedelics startup a market capitalization of $3.19 billion.
The Berlin-based biotech startup, which is exploring the use of psychedelic treatments for mental illnesses, raised $225 million from selling 15 million shares in its upsized initial public offering on Thursday.
==============================================
I think that there is a lot of potential here. Psilocybin has been used in cognitive therapy & ibogaine is used in substance withdrawal.